These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1450434)

  • 1. Aminergic control of vasopressin secretion in the conscious rat.
    Wells T; Forsling ML
    J Physiol Pharmacol; 1992 Mar; 43(1):59-64. PubMed ID: 1450434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasopressin release in response to hypovolaemia in the conscious rat and the effect of opioid and aminergic receptor antagonists.
    Peysner K; Forsling ML
    J Physiol Pharmacol; 1991 Sep; 42(3):317-26. PubMed ID: 1686565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Facilitatory role of central dopamine in the osmotic release of vasopressin.
    Yamaguchi K; Hama H
    Brain Res; 1989 Mar; 481(2):388-91. PubMed ID: 2720392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible contribution of dopaminergic receptors in the anteroventral third ventricular region to hyperosmolality-induced vasopressin secretion in conscious rats.
    Yamaguchi K; Hama H; Watanabe K
    Eur J Endocrinol; 1996 Feb; 134(2):243-50. PubMed ID: 8630527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of the pressor action of LY171555, a specific dopamine D2 receptor agonist, in the conscious rat.
    Nagahama S; Chen YF; Lindheimer MD; Oparil S
    J Pharmacol Exp Ther; 1986 Mar; 236(3):735-42. PubMed ID: 2869141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of forebrain GABA receptors in controlling vasopressin secretion and related phenomena under basal and hyperosmotic circumstances in conscious rats.
    Yamaguchi K; Yamada T
    Brain Res Bull; 2008 Sep; 77(1):61-9. PubMed ID: 18639747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of the vasopressin response of rats to intraperitoneal and intravenous administration of hypertonic saline, and the effect of opioid and aminergic antagonists.
    Forsling ML; Matziari C; Aziz L
    J Endocrinol; 1988 Feb; 116(2):217-24. PubMed ID: 3351418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of anteroventral third ventricular AMPA/kainate receptors in both hyperosmotic and hypovolemic AVP secretion in conscious rats.
    Yamaguchi K; Yamada T
    Brain Res Bull; 2006 Dec; 71(1-3):183-92. PubMed ID: 17113945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Participation of periventricular dopamine receptors in vasopressin secretion elicited by hypertonicity of systemic blood in rats.
    Yamaguchi K; Hama H
    Acta Endocrinol (Copenh); 1991 Apr; 124(4):455-62. PubMed ID: 2031443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of hypothalamic norepinephrine does not alter the osmoregulation of vasopressin in rats.
    Kamoi K; Henry DP; Robertson GL
    Endocrinology; 1984 Jun; 114(6):2123-7. PubMed ID: 6144538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced cardiovascular alteration and Fos expression induced by central salt loading in a conscious rat transgenic for the metallothionein-vasopressin fusion gene.
    Chu CP; Kato K; Jin QH; Qiu DL; Yu NS; Oiso Y; Kannan H
    Neurosci Res; 2005 Oct; 53(2):147-55. PubMed ID: 16039738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pursuit of roles for metabotropic glutamate receptors in the anteroventral third ventricular region in regulating vasopressin secretion and cardiovascular function in conscious rats.
    Yamaguchi K; Watanabe K
    Brain Res Bull; 2004 May; 63(4):321-9. PubMed ID: 15196658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central effects of catecholamine antagonists on angiotensin-induced vasopressin secretion in conscious rats.
    Yamaguchi K; Karakida T; Koike M; Hama H
    Acta Endocrinol (Copenh); 1988 May; 118(1):82-8. PubMed ID: 3389051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The vasopressin response to centrally administered hypertonic solutions in the conscious rat.
    Wells T; Forsling ML; Windle RJ
    J Physiol; 1990 Aug; 427():483-93. PubMed ID: 2120429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of vasopressin in the cardiovascular effects of LY171555, a selective dopamine D2 receptor agonist: studies in conscious Brattleboro and Long-Evans rats.
    Nagahama S; Ann HS; Chen YF; Lindheimer MD; Oparil S
    J Pharmacol Exp Ther; 1987 Jul; 242(1):143-51. PubMed ID: 2956409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central administration of orexin A suppresses basal and domperidone stimulated plasma prolactin.
    Russell SH; Kim MS; Small CJ; Abbott CR; Morgan DG; Taheri S; Murphy KG; Todd JF; Ghatei MA; Bloom SR
    J Neuroendocrinol; 2000 Dec; 12(12):1213-8. PubMed ID: 11106980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central nitric oxide blocks vasopressin, oxytocin and atrial natriuretic peptide release and antidiuretic and natriuretic responses induced by central angiotensin II in conscious rats.
    Reis WL; Giusti-Paiva A; Ventura RR; Margatho LO; Gomes DA; Elias LL; Antunes-Rodrigues J
    Exp Physiol; 2007 Sep; 92(5):903-11. PubMed ID: 17513344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory role of periventricular dopaminergic mechanisms in hemorrhage-induced vasopressin secretion in conscious rats.
    Yamaguchi K; Hama H; Adachi C
    Brain Res; 1990 Apr; 513(2):335-8. PubMed ID: 2350705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central cardiovascular effects of vasotocin, oxytocin and vasopressin in conscious rats.
    Feuerstein G; Zerbe RL; Faden AI
    J Pharmacol Exp Ther; 1984 Feb; 228(2):348-53. PubMed ID: 6694114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Centrally administered interleukin-1 beta sensitizes to the central pressor action of angiotensin II.
    Ufnal M; Dudek M; Zera T; Szczepańska-Sadowska E
    Brain Res; 2006 Jul; 1100(1):64-72. PubMed ID: 16765325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.